Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation
about
Emerging role of Hippo pathway in gastric and other gastrointestinal cancersThe role of the Hippo pathway in human disease and tumorigenesisConnexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis.Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma.New genetic variants of LATS1 detected in urinary bladder and colon cancer.Disease implications of the Hippo/YAP pathway.Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.Contribution of LATS1 and LATS2 promoter methylation in OSCC development.LATS1 suppresses proliferation and invasion of cervical cancer.Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation.Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancer.The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.miR-21 inhibition of LATS1 promotes proliferation and metastasis of renal cancer cells and tumor stem cell phenotype.Characterization of Hippo Pathway Components by Gene Inactivation.Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer.Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer
P2860
Q26774473-EFE3BA7A-86AE-4E35-9564-EC977681835CQ30433413-DAD1C041-B68C-453D-A6EC-EB35C119447CQ34137351-45244D7A-389A-43D0-A1DF-A146B13A2C8BQ34767097-07E425D1-235C-44D0-87C3-C2255005D878Q34936987-BF9A6009-8856-4C33-9026-48450DC66019Q35269102-3EBF23DB-A26B-4AD7-9608-870FCF2DA47FQ35939528-8B387EBC-C680-4C59-9B6A-3157AF6F9278Q37716706-646714D6-E699-4E53-AAA8-D4EFC854B3FFQ37720180-54DA5325-C356-4223-8CF1-779ABD5DCB78Q38362961-1B53E120-BEDF-449F-8622-E6104E541BACQ38703047-5F2E09F8-AD61-4996-8EC0-C7D96586F6CFQ39394211-66498629-598E-4B9C-8300-E3BE948FE0C1Q43290522-691350B6-A1DA-45E3-8B38-724DCAE5EF45Q45423657-6450BB42-20DD-4AB4-8211-A3B87417FD69Q47128149-FD5AD496-52E8-4314-8185-7F026595581BQ50707850-35AD8517-B4FA-4186-8EFE-28A5DEEF5BF4Q54247052-939A1395-9D4E-442F-8015-17AD4258E3E3Q57782091-67C97303-FBF4-42AF-9904-B185A31322A6
P2860
Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Underexpression of LATS1 TSG i ...... with promoter hypermethylation
@en
Underexpression of LATS1 TSG i ...... ith promoter hypermethylation.
@nl
type
label
Underexpression of LATS1 TSG i ...... with promoter hypermethylation
@en
Underexpression of LATS1 TSG i ...... ith promoter hypermethylation.
@nl
prefLabel
Underexpression of LATS1 TSG i ...... with promoter hypermethylation
@en
Underexpression of LATS1 TSG i ...... ith promoter hypermethylation.
@nl
P2093
P2860
P356
P1476
Underexpression of LATS1 TSG i ...... with promoter hypermethylation
@en
P2093
Anna Kowalczyk
Bartlomiej Korybalski
Dorota Kartanowicz
Iwona Skwierz-Bogdanska
Janusz Godlewski
Krystian Adrych
Krzysztof Celinski
Tomasz Gach
Zbigniew Kmiec
P2860
P304
P356
10.3748/WJG.V19.I27.4363
P407
P577
2013-07-01T00:00:00Z